Fenju Liu

Fenju Liu

Auto-generated profile, based on publicly available information

Fenju Liu

State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Suzhou 215123, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Experimental Cell Research
Verified
Journal Article
Closed access
XYXiaopeng Yuan
Xiaopeng Yuan
JDJie Du
Jie Du
SHSong Hua
Song Hua
HZHaowen Zhang
Haowen Zhang
CGCheng Gu
Cheng Gu
FLFenju Liu
Fenju Liu

13 February 2015 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
YZYuan Zhou
Yuan Zhou
SHSong Hua
Song Hua
JYJiahua Yu
Jiahua Yu
PDPing Dong
Ping Dong
FLFenju Liu
Fenju Liu
DHDaoben Hua
Daoben Hua
Effective radioprotection is achieved by chitosan-based long-circulating nanocarriers with radioprotective agents. The stable encapsulation does not reduce its radioprotective capability and exhibits prolonged retention time, thereby showing more beneficial effects.

1 April 2014 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
HZHaowen Zhang
Haowen Zhang
CGCheng Gu
Cheng Gu
JYJiahua Yu
Jiahua Yu
ZWZhongmin Wang
Zhongmin Wang
XYXiaopeng Yuan
Xiaopeng Yuan
FLFenju Liu
Fenju Liu

25 April 2013 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
WYWei Yang
Wei Yang
JWJing Wei
Jing Wei
TSTing Sun
Ting Sun
FLFenju Liu
Fenju Liu
Solid tumors usually develop local hypoxia, which renders them resilient to radiotherapy. MiR-210 is the most consistently and robustly induced miRNA under hypoxia and functions as a micro-controller of a wide range of cellular responses to hypoxia. Hence, it is important to investigate the effect of knockdown of miR-210 in tumorigenesis and evaluate the efficacy of knockdown of miR-210 in combination with radiotherapy on human tumor xenograft in nude mice. SMMC-7721 Cells with stable integration of the anti-sense miR-210 were generated through lentiviral-mediated gene transfer and were subcutaneously implanted into nude mice. Mice were monitored for tumor growth and survival after radiotherapy. MiR-210 expression in tumor tissues was assessed by real-time Reverse transcription-Polymerase Chain Reaction (RT-PCR). Protein expression of HIF-1α and miR-210 targeted genes in human hepatoma xenograft was assessed by Western blot. Tumors were analyzed for proliferation, apoptosis, and angiogenesis biomarkers by immunohistochemistry staining. Tumor growth was delayed in miR-210 downregulated xenograft. Knockdown of miR-210 increased protein expression of miR-210 targeted genes, but decreased HIF-1α protein in hepatoma xenograft. Knockdown of miR-210 in combination with radiotherapy is more effective than radiotherapy alone or miR-210 knockdown therapy alone in suppressing tumor growth and extending survival duration. Combined therapy decreased Ki-67-positive cells and CD31-positive cells and increased TUNEL-positive cells in tumor xenograft. Knockdown of miR-210 in combination with radiotherapy showed an enhanced anti-tumor effect on human hepatoma xenograft. Our experiments demonstrated specific inhibition of miR-210 expression might be a means to enhance the effectiveness of radiotherapy to human hepatoma.

10 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
JHJian-Feng Huang
Jian-Feng Huang
FZFu-Zheng Zhang
Fu-Zheng Zhang
QZQin-Zhou Zou
Qin-Zhou Zou
LZLe-Yuan Zhou
Le-Yuan Zhou
BYBo Yang
Bo Yang
CMC-M Charlie Ma
C-M Charlie Ma
Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial

15 May 2010 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
PDF file
WYWei Yang
Wei Yang
TSting sun
ting sun
JCJianping Cao
Jianping Cao
FLFenju Liu
Fenju Liu
Purpose: To investigate the effect of survivin-short hairpin RNA (shRNA) on the proliferation, apoptosis and radiosensitivity of human hepatoma SMMC-7721 cells. Materials and methods: Survivin-targeted small interfering RNA (siRNA) expression vector was constructed and transfected into SMMC-7721 cells mediated by cationic liposome. Survivin mRNA and protein expression were analysed by reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting. Cell viability was measured by 3-(4, 5-dimethylthiazol-2-yl)- 2, 5-diphenyl tetrazolium bromide (MTT) assay. Cell cycle and apoptosis were measured by flow cytometry (FCM) assay. Radiosensitivity of SMMC-7721 cells was examined using a colony-forming assay. Mice subcutaneously implanted with SMMC-7721 cells were monitored for tumour growth and survival after treatment, and tumours were analysed for proliferation, apoptosis, and angiogenesis biomarkers by immunohistochemistry staining. Results: After transfection, the mRNA and protein expression of survivin gene in SMMC-7721 cells downregulated, which led to significant cell growth inhibition, cell arrest in G2/M phase, increased apoptotic rate and radiosensitivity. Survivin-shRNA in combination with radiotherapy was more effective than radiotherapy or survivin-shRNA therapy alone in suppressing tumour growth and extending survival duration. Combined therapy inhibited cell proliferation and tumour angiogenesis and increased apoptosis in tumour xenografts. Conclusion: Survivin downregulation by siRNA/cationic liposome inhibited proliferation, induced apoptosis and enhanced radiosensitivity in human hepatoma cells in vitro and in vivo.